Background: Only few data evaluating the prognostic impact of blood-derived potassium
levels (K) on arrhythmic endpoints in patients with implantable cardioverter-defibrillators …

Background The study sought to assess the prognostic impact of potassium levels (K) in
patients with ventricular tachyarrhythmias. Methods A large retrospective registry was used …

Serum Potassium and Defibrillator Shocks. Introduction: Electrolyte abnormalities are
considered a correctable cause of a life‐threatening ventricular arrhythmia according to …

Background Low plasma potassium (pK) is associated with increased risk of malignant
arrhythmia and observational studies indicate protective effects of pK in the upper reference …

We present the case of a 74-year-old man with non-ischemic dilatated cardiomyopathy and
an implantable cardioverter-defibrillator presenting with a serum potassium of 2.6 mmol/L …

The study sought to assess the impact of chronic kidney disease (CKD) on recurrences of
ventricular tachyarrhythmias in implantable cardioverter defibrillator (ICD) recipients. Data …

Background Potassium replenishment protocols are often employed across broad patient
populations to prevent cardiac arrhythmias. Tailoring potassium thresholds to specific …

BACKGROUND: Indications for implantable cardioverter defibrillator (ICD) implantation are
expanding, but many primary and secondary ICD trials have excluded patients with …

TO BE PROVOCATIVE and to draw attention to the problem rather than resolve it, I suggest
semifacetiously that a debate might be staged with the title: Resolved: That more lives have …

Background The incidence of dyskalemias and associated outcomes in acute myocardial
infarction (AMI) are unknown in real-world settings and likely differ from the controlled …